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Heisig et al. show that IAFGP, a tick anti-
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confer cold resistance, also functions as
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tion. IAFGP prevents bacterial biofilm
formation in multiple pathogens, and a
homologous synthetic peptide shows po-
tential for application in medical
applications.
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As microbial drug-resistance increases, there is a
critical need for new classes of compounds to com-
bat infectious diseases. The Ixodes scapularis tick
antifreeze glycoprotein, IAFGP, functions as an anti-
virulence agent against diverse bacteria, including
methicillin-resistant Staphylococcus aureus. Recom-
binant IAFGP and a peptide, P1, derived from this
protein bind to microbes and alter biofilm formation.
Transgenic iafgp-expressing flies and mice chal-
lenged with bacteria, as well as wild-type animals
administered P1, were resistant to infection, septic
shock, or biofilm development on implanted catheter
tubing. These data show that an antifreeze protein fa-
cilitates host control of bacterial infections and sug-
gest therapeutic strategies for countering pathogens.
INTRODUCTION
Diverse ectotherms tolerate the cold by altering the temperature
at which their tissues freeze or by preventing the damage caused
by the formation of ice (Doucet et al., 2009). Major mechanisms
of cold adaptation include the accumulation of solvents to lower
the freezing point and the synthesis of antifreeze proteins (AFPs)
that bind ice crystals (Davies and Sykes, 1997). AFPs prevent
the growth of ice crystals in a noncolligative manner, lowering
the freezing point of the solution. Additional properties of AFPs
include the inhibition of ice recrystallization or cell membrane
stabilization at low temperatures (Davies and Sykes, 1997;
Venketesh and Dayananda, 2008). Antifreeze glycoproteins
(AFGPs), a class of AFPs, are characterized by canonical
Ala-Ala-Thr (AAT) or Pro-Ala-Thr (PAT) repeats with a b-D-galac-
tosyl-(1/3)-a-N-acetyl-D-galactosamine disaccharide atta-
ched to each threonine (Carvajal-Rondanelli et al., 2011). Arctic
fish AFGPs contain between 4 and 55 repeats, and AFGPs of
different lengthmay synergize, suggesting functional differences
encoded into the number of tripeptide repeats and spacer se-
quences between them (Garner and Harding, 2010).CIxodes scapularis ticks are seasonally exposed to cold
temperatures in northern latitudes (Brownstein et al., 2003).
We recently identified an I. scapularis AFGP, named IAFGP
(Neelakanta et al., 2010). iafgp expression in ticks and in iafgp-
transgenic fruit flies correlated with increased survival at low
temperatures (Neelakanta et al., 2010, 2012). Interestingly, iafgp
expression in the tick was upregulated, both in the cold and upon
infestation with a common I. scapularis-borne pathogen, Ana-
plasma phagocytophilum, the agent of human granulocytic
anaplasmosis (Neelakanta et al., 2010). Expression of iafgp did
not diminish the A. phagocytophilum burden within ticks (Neela-
kanta et al., 2010). Overall, these data suggest a form of mutu-
alism, in which a microbe enhances the capacity of its arthropod
vector to survive in the cold, thereby indirectly increasing its own
potential to be transmitted to a vertebrate host. For some plant
AFPs, chitinase or glucanase activity has been shown in vitro,
suggesting that these proteins may have additional properties
(Griffith and Yaish, 2004; Huang and Duman, 2002; Meyer
et al., 1999; Yaish et al., 2006; Zhang et al., 2007). Here we inves-
tigate the influence of IAFGP on infection with Staphylococcus
aureus and other bacteria in vitro and in vivo.RESULTS
In Vitro Activity of IAFGP
IAFGP contributes to I. scapularis and Drosophila melanogaster
resistance against cold stress (Neelakanta et al., 2010, 2012).
Here we examine whether IAFGP is also involved in the host-
pathogen response. Recombinant glutathione S-transferase
(GST)-tagged IAFGP, but not GST alone, bound to various bac-
teria, purified peptidoglycan was sufficient for IAFGP binding
(Figures 1A and 1B). In vitro, the addition of GST-IAFGP did
not alter planktonic growth of the microbes; however, it strongly
interfered with biofilm formation in static S. aureus cultures
(Figures 1C and S1A). Although mock- or GST-treated bacteria
established a biofilm in glucose-supplemented medium, GST-
IAFGP-treated microorganisms showed significantly reduced
biofilm formation (Figure 1C; p < 0.001). Immunoblot data
demonstrated decreased amounts of the exopolysaccharide
poly-N-acetylglucosamine (PNAG), a major biofilm component,ell Reports 9, 417–424, October 23, 2014 ª2014 The Authors 417
Figure 1. IAFGP Binds Bacteria and Alters
Microbial Biofilm Formation In Vitro
(A) Escherichia coli (EC), Serratia marcescens
(SM), Pseudomonas entomophila (PE), Listeria
monocytogenes (LM), Staphylococcus aureus
SA113 (SA), or Staphylococcus aureus USA300
JE2 (USA300) were incubated with recombinant
GST or GST-IAFGP (input). Bound protein (asso-
ciated) was detected by immunoblot analysis.
Recombinant GST-IAFGP or GST alone was used
as positive control respectively (pos ctrl).
(B) Insoluble S. aureus peptidoglycan was incu-
batedwith recombinant GSTorGST-IAFGP (input),
respectively, andwash fractions (wash1–3) and the
peptidoglycan-containing pellet (associated) were
probed for protein content by immunoblot analysis.
Without protein incubation peptidoglycan showed
no detectable signal (neg ctrl).
(C) Biofilm formation of S. aureus cultures
supplemented with GST or GST-IAFGP was
measured using Safranin stains. In addition to
S. aureus SA113, the methicillin-resistant USA300
JE2 isolate was investigated. Results are means ± SEM of three independent experiments performed in duplicate, with representative images of the stained
biofilm below (one-way ANOVA with Tukey’s posttest). Bacteria cultured in BHI/G (Medium) or supplemented with protein purification elution buffer (Buffer
control) served as controls.
(D) PNAG levels of S. aureus SA113 and the USA300 JE2 isolate supplemented with GST or GST-IAFGP were assessed using immunoblot analysis. Results are
means ± SEM of three independent experiments (one-way ANOVA with Tukey’s posttest). Bacteria cultured in BHI/G (medium) without protein addition were
used as reference.in bacteria exposed to GST-IAFGP (Figure 1D; p < 0.001). Similar
to a prototypic S. aureus strain (SA113), a methicillin-resistant
S. aureus (MRSA) isolate (USA300), which is an important
drug-resistant organism that causes substantial clinical disease,
also bound GST-IAFGP, resulting in biofilm and PNAG suppres-
sion (Figures 1A, 1C, and 1D; p < 0.001 and p < 0.01).
The vast majority of the primary amino acid sequence of IAFGP
contains highly conserved peptide repeats. Except for the pre-
dicted N-terminal secretion signal, IAFGP is composed of repeats
consisting of the canonical AFGPamino acid triplets AAT and PAT
interspersed between a six amino acid spacer sequence Pro-Ala-
Arg-Lys-Ala-Arg (PARKAR), approximately every 21 amino acids
(Figure S1B). Eight of the 10 IAFGP repeats share a high level of
identity, and the other two show variations in the spacer
sequence. We therefore investigated whether individual repeats
might also be involved in antimicrobial activity. We synthesized
a peptide (P1) with hallmarks of this domain, including a PARKAR
spacer followed by six AAT triplets, to investigate this region’s
binding affinity for bacteria and antimicrobial activity (Figure S1C).
We chose S. aureus as a model organism, as it is a gram-positive
pathogen of great clinical importance.We extended our studies to
Listeriamonocytogenes,Pseudomonas entomophila, andSerratia
marcescens to include an additional gram-positive agent and
gram-negative microbes. Similar to the full-length protein, P1
bound to different bacterial species (Figure 2A). Peptide binding
competed with IAFGP for binding to the microbes, while scram-
bled P1 (sP1) served as a control (Figure 2B). Likewise to IAFGP,
P1 abrogated S. aureus biofilm formation and PNAG levels under
static culture conditions, but did not influence bacterial viability
(Figures 2C, 2D, and S1D; p < 0.001 and p < 0.001). These data
demonstrate that IAFGP and P1 directly bind gram-positive and
gram-negative pathogens and have antibiofilm properties.418 Cell Reports 9, 417–424, October 23, 2014 ª2014 The Authorsiafgp-Expressing D. Melanogaster Show Resistance
to Bacterial Infection
iafgp-expressing D. melanogaster (Neelakanta et al., 2012) were
used to study the anti-infective activity of IAFGP in inverte-
brates. Fly infection by microinjection with S. aureus showed
enhanced survival in comparison to controls (Figure 3A; p <
0.001). Needle prick infection with L. monocytogenes or oral
infection with S. marcescens or P. entomophila also showed
increased survival of iafgp-transgenic flies, indicating a broad
spectrum of protection (Figures S2A–S2C; p < 0.05, p < 0.001,
and p < 0.001). To discriminate between tolerance or resistance
mechanisms causing the increase in survival, the pathogen load
was quantified. The bacterial burden in control flies increased for
4 days, demonstrating microbial growth. In contrast, the path-
ogen titers in iafgp-expressing flies remained stable over the
course of infection, indicating either reduced replication or
growth homeostasis with host-induced killing (Figure 3B). Bac-
terial titers in transgenic and control flies showed significant dif-
ferences 2–4 days after challenge, suggesting that IAFGP is
involved in infection resistance (Figure 3B; p < 0.001, p < 0.01,
and p < 0.05).
We then assessed whether increased resistance of iafgp-
expressing flies to S. aureus was due to a more efficient host
response to infection or a direct effect on the bacteria. Fly immu-
nity is comprised of three innate effector mechanisms. Hemo-
cytes similar to macrophages engulf pathogens, antimicrobial
peptides (AMPs) exert direct bactericidal effects, and melanin
deposition leads to microbe encapsulation (Kim and Kim,
2005). All effector mechanisms contribute to the response
against a S. aureus challenge (Nehme et al., 2011). Blocking fly
phagocytosis or melanization during S. aureus infection affected
survival of iafgp-expressing and control flies to a similar extent
Figure 2. Binding of P1 to Staphylococcus
Aureus Interferes with Biofilm Formation
In Vitro
(A) S. aureus SA113, the methicillin-resistant
USA300 JE2 isolate, L. monocytogenes EGDe,
and E. coli DH5a were incubated with biotinylated
P1 (pos ctrl) in DMSO. Following washing, bound
peptide was detected by immunoblot. DMSO or
SA113 without peptide incubation served as
negative controls.
(B) S. aureus SA113 and USA300 were pre-
incubated in PBS supplemented with P1 or sP1
before incubation with GST-IAFGP. Following
removal of unbound GST-IAFGP, GST-IAFGP
associated with the bacterial pellet was detected
by immunoblot. Recombinant GST-IAFGP was
used as positive control for immunoblot.
(C) Biofilm formation of S. aureus SA113 and
USA300 JE2 cultures supplemented with P1 or
sP1 were measured with Safranin stains. Results
are means ± SEM of three independent experi-
ments performed in quadruplicate; representative
images of the biofilm stain are shown (one-way
ANOVA with Tukey’s posttest). Bacteria cultured in BHI/G (Medium) or supplemented with PBS serve as controls.
(D) PNAG formation of S. aureus supplemented with P1 or sP1 was visualized by immunoblot. Results are means ± SEM of three independent experiments, with
representative images of the stained biofilm (one-way ANOVA with Tukey’s posttest). Bacteria cultured in BHI/G (Medium) without protein addition were used as
reference.(Figures S3A and S3B; p < 0.001, p < 0.001) and AMP expression
levels were not increased by IAFGP (Figure S4), suggesting that
the anti-infective function of IAFGP was not mediated through a
direct effect on fly immunity. Consistent with the in vitro observa-
tions, the PNAG quantity during S. aureus infection was reduced
in iafgp-expressing flies compared with controls (Figure 3C; p <
0.001). Immunohistochemical detection of S. aureus and PNAG
in infected flies confirmed diminished bacterial colonization
and the decrease in PNAG (Figure 3D). When flies were chal-
lenged with a PNAG-deficient S. aureus DicaADBC mutant, the
protective effect of IAFGPwas completely abrogated (Figure 3E).
These data show that the anti-infective function of IAFGP in flies
correlates with bacterial PNAG synthesis on S. aureus challenge.
iafgp-Expressing Mice Show Increased Survival
following Bacterial Challenge and Sepsis
As IAFGP shows anti-infective activity in vitro and in an inverte-
brate model of infection, we assessed whether IAFGP has a
similar function in vertebrates. We generated a transgenic
mouse line expressing iafgp ubiquitously (Figure S5A). Mice
were subjected to cecal ligation and puncture (CLP), a well-char-
acterized model of polymicrobial sepsis (Rittirsch et al., 2009).
We observed increased survival of iafgp-expressing mice in
comparison to controls after CLP surgery, reflected by a 35%
extended average survival time (Figure 4A; p < 0.05). Hypother-
mia was delayed, and serum cytokine release of MCP-1, a
marker of sepsis, was reduced in iafgp-expressing mice
compared with control animals (Figures 4B and S5B; p <
0.001). The transgenic animals also recorded significantly better
general health and activity at 24–36 hr after surgery than control
mice (Figure 4C; p < 0.05). A monomicrobial intranasal challenge
with MRSA also demonstrated enhanced survival of iafgp-trans-
genic mice compared with controls (Figure 4D; p < 0.05). Collec-Ctively, these results show that IAFGP affords protection for mice
against bacterial infection.
Coating of Catheter Biomaterial with P1 Prevents
Biofilm Formation
Staphylococci are responsible for half of the catheter-related
bloodstream infections in the United States (Maki et al., 2006;
Ramos et al., 2011). S. aureus accounts for at least 20% of these
infections and is associated with high morbidity and mortality
(Walz et al., 2010). To investigate whether IAFGP or P1 interfere
with bacterial attachment to biomaterials, we incubated intrave-
nous catheters in protein or peptide solution and then transferred
them into S. aureus suspensions. IAFGP and P1 spontaneously
associated with the catheters and reduced biofilm formation
(Figure 5A). Associated bacteria were lowered 9- and 40-fold,
respectively, in comparison to untreated controls (Figure 5A;
p < 0.05). To investigate biofilm formation in vivo, P1-coated
catheters were implanted subcutaneously into mice and inocu-
lated with S. aureus. Seventy-two hours later, the catheters
were removed and examined for bacterial attachment and bio-
film formation. P1-coated catheters demonstrated a 40-fold
reduction in the number of attached bacteria in comparison to
mock-treated catheters (Figure 5B; p < 0.001). Scanning elec-
tron microscopy further showed that catheters coated with P1
had a marked reduction of PNAG in S. aureus biofilms (Fig-
ure 5C). The altered biofilm formation on biomaterials confirmed
the in vivo activity of P1 and suggests its application as prophy-
lactic coating to prevent bacterial attachment.
DISCUSSION
These data collectively demonstrate the antivirulence properties
of an AFP. Bacterial binding of IAFGP or P1 correlated withell Reports 9, 417–424, October 23, 2014 ª2014 The Authors 419
Figure 3. iafgp Expression Reduces Drosophila Susceptibility to Staphylococcus Aureus Challenge In Vivo
(A) iafgp-transgenic and mCherry control flies (n = 150/180) were challenged with 500–1,000 CFU S. aureus SA113. Sham animals received PBS injections only.
Survival data were pooled from three independent experiments (log rank test).
(B) iafgp-transgenic and control flies were challenged with 50–100 CFUS. aureus SA113. Bacterial colonization of individual flies was determined by plating serial
dilutions. Data were pooled from three independent experiments. Box plot extends from the 25th to 75th percentiles, whiskers from the 10th to 90th percentiles, the
line inside the box represents the median CFU (two-way ANOVA with Sidak’s posttest).
(C) iafgp-transgenic and control flies were challenged with 500–1,000 CFU S. aureus SA113. PNAG levels of pools of five flies were assessed at different time
points by immunoblot. Relative signal intensity to noninfected (n.i.) flies is shown. Average signal intensities of three independent experiments ± SEM with
representative immunoblot images are shown (two-way ANOVA with Sidak’s posttest).
(D) iafgp-transgenic and control flies were challenged with 500–1,000 CFU S. aureus SA113. Paraffin sections of whole flies 24 hr postinfection were stained for
bacteria (Gram stain) and PNAG (WGA, brown color). Black triangles point to bacteria; white triangles indicate PNAG. Inlet pictures show a magnified area with
individual bacterial cells; the scale bar length is 100 mm.
(E) iafgp-transgenic and control flies (n = 150/180) were challenged with 500–1,000 CFU S. aureus SA113 DicaADBC, deficient in PNAG production. Survival data
were pooled from four independent experiments (log rank test).inhibition of biofilm formation in S. aureus and translated into
increased host survival following bacterial challenge. Since
expression of genes encoding exopolysaccharide (PNAG)
formation was not decreased (Figure S5C), we postulate that
binding of IAFGP or P1 interferes with envelope structure or
associated proteins, affecting cellular signaling or PNAG secre-
tion and assembly.
S. aureus exopolysaccharide protects bacteria against at-
tacks of the host response by inactivating phagocytic cells and
providing a barrier against bactericidal compounds, such as
AMPs or antibiotics (Vuong et al., 2004; Nishimura et al., 2006).
Immunocompromised flies lacking AMP expression did not420 Cell Reports 9, 417–424, October 23, 2014 ª2014 The Authorsbenefit from iafgp during infection (data not shown). Together
these data suggest that IAFGP binding to S. aureus and the
associated reduction in biofilm formation lead to a greater sus-
ceptibility of the pathogen to the immune response of the fly
host but not an altered immune response, supporting the antivir-
ulence function of IAFGP.
In warm-blooded animals, a drop of the body core tempera-
ture in response to cold environments results in cell damage
and death before tissues freeze (Boutilier, 2001; Long et al.,
2005). Collectively, our data show that an AFP has antivirulence
activity, mediated by rendering the bacteria more susceptible to
immune clearance following the prevention of biofilm formation.
Figure 4. iafgp-Expressing Mice Show Increased Resistance to Polymicrobial Sepsis or Staphylococcus Aureus USA300 JE2 Challenge
(A–C) iafgp-transgenic mice and C57Bl/6 wild-type animals (n = 15/16) underwent CLP surgery. Results were pooled from five independent experiments. Mice of
both genotypes (n = 5), receiving sham surgery without CLP, were used as controls. (A) Murine survival (log rank test), (B) body temperature (two-way ANOVAwith
Sidak’s posttest), and (C) disease score (two-way ANOVA with Sidak’s posttest) are shown.
(D) iafgp-transgenic mice and C57Bl/6 wild-type animals (n = 24/18) were challenged intranasally with S. aureus USA300 JE2. Pooled mouse survival of two
independent experiments at 36 hr after infection is shown (chi-square test).In ectotherms, low environmental temperatures cause a reduc-
tion of the body temperature, therefore limiting available energy
due to diminished nutrient uptake and metabolic activity (Turk,
2010; Storey and Storey, 2013). As these organisms cool they
become less effective at combatting pathogens (Bouma et al.,
2013; Triggs and Knell, 2012). Moreover, when organisms
warm after a period of cooling, they may remain more suscepti-
ble to bacterial infection until they have increased their temper-
ature and regained their optimal metabolic activity. From an
evolutionary perspective, it would be beneficial if a molecule
that facilitated survival in the cold also afforded protection
against microorganisms. IAFGP represents the first identified
broad-spectrum antivirulence protein, and it will be interesting
to determine whether other classes of (antifreeze) proteins also
exhibit this activity (Allen et al., 2014). These studies also have
substantial practical implications and suggest therapeutic stra-
tegies to prevent or control bacterial disease in humans,
including infections associated with implanted biomaterials,
either directly or in synergy with traditional antibiotics.
EXPERIMENTAL PROCEDURES
Cloning, Expression, and Purification of IAFGP
iafgp lacking the predicted secretion signal was PCR amplified from pGEMT-
iafgp (Neelakanta et al., 2010) using oligomers pGEX-F and pGEX-RL, digested
with EcoRI and XhoI and cloned into pGEX-6p-3 (GE Healthcare). Protein
expression was induced with 1 mM IPTG for 3 hr at 37C, and bacteria were
lysed using a French pressure cell press at 20,000 pounds per square inch.
Following centrifugation, GST-IAFGP was affinity purified using GST Sephar-
ose (GE Healthcare), eluted (elution buffer; 50 mM Tris-HCl, 10 mM reduced
glutathione [pH 8.0]), and stored in aliquots at80C. Precision protease treat-
ment or dialysis resulted in IAFGP degradation. Therefore, the GST-tagged
protein in elution buffer was used for experiments. Recombinant GST was pu-
rified from pGEX-6p-3 following the same protocol and used as a control.CProtein/Peptide Binding Assays and Immunoblot Analysis
One to 23 107E. coliDH5a,S.marcescensDb11 (GFP),P. entomophila (GFP),
L. monocytogenes EGDe, S. aureus SA113, or S. aureus USA300 JE2 in sta-
tionary growth phase were washed, resuspended in 100 ml PBS or DMSO
(Life Technologies; assays involving biotinylated P1 were performed in
100% DMSO; Sigma-Aldrich), and recombinant GST, GST-IAFGP, or bio-
tinylated peptide was added (1.6 mM and 0.9 mMor 6.9 mM final concentration,
respectively). Supernatant was removed after 10 min incubation at 37C, and
the pellet was washed three times in 0.1% Triton X-100 (Sigma-Aldrich) in PBS
or in 100%DMSO. Proteins were mixed with loading dye, heat denatured, and
size separated by SDS-PAGE. Immunoblot using a polyclonal murine serum
raised against GST-IAFGP or GST monoclonal antibody (Sigma-Aldrich) was
used for specific protein detection. Peptide samples were spotted on polyvi-
nylidene fluoride membrane, dried, and probed with infrared (IR)-labeled
streptavidin (LI-COR). The LI-COR Odyssey system was used to visualize
IR-labeled secondary probes (LI-COR). To investigate peptidoglycan binding,
28 mg S. aureus peptidoglycan (Sigma-Aldrich) were incubated for 10 min with
recombinant GST-IAFGP, GST, or biotinylated P1 (416 mM) in PBS or DMSO,
respectively, and washed three times, and bound protein or peptide was de-
tected as described above. The impact of peptide preincubation on IAFGP
binding to bacteria was investigated. Following incubation of washed bacteria
for 30 min at 37C with 0.2 mg/ml peptide (92.7 mM; KECK Biotechnology
Resource Laboratory; heat dissolved in PBS), the bacterial pellet was washed
three times in 0.1% Triton X-100 in PBS, and IAFGP binding was assayed as
described above. PNAG detection was performed as described using rabbit
antisera against PNAG (Cramton et al., 1999). In brief, following incubation
of S. aureus with proteins or peptides, PNAG was released into the super-
natant by boiling in 0.5 M EDTA. Proteins were digested by Proteinase K
treatment. Finally, insoluble components were sedimented by centrifugation
before loading the samples on nitrocellulose membranes for detection by
immunoblot.
Static Biofilm Assay
Biofilm assays were performed as described (Christensen et al., 1985). In brief,
planktonic overnight cultures of S. aureus were diluted in glucose-supple-
mented tryptic soy broth or brain-heart infusion broth (1% glucose) to
OD600 = 0.015 and distributed into 96 well plates (Corning). Plates wereell Reports 9, 417–424, October 23, 2014 ª2014 The Authors 421
Figure 5. P1 Associates with Intravenous Catheters and Restricts
Staphylococcus Aureus Biofilm Formation In Vitro and In Vivo
(A) Intravenous catheter tubing was preincubated in protein elution buffer
(Buffer) supplemented with GST or GST-IAFGP or in PBS supplemented with
P1 or sP1 before transferring into S. aureus SA113 suspensions. Bacterial
attachment was quantified after sonication by plating serial dilutions. Average
CFU values pooled from three independent experiments ± SEM are shown
(protein and peptide data: one-way ANOVA with Tukey’s posttest).
(B) Intravenous catheters were incubated for 24 hr in PBS, P1, or sP1 and
washed and implanted subcutaneously into the dorsal flanks of C57Bl/6 mice
(n = 5/6/6); 72 hr after catheter inoculation with 53 105 CFU S. aureus SA113,
the catheters were removed, and the attached bacteria were quantified by
plating serial dilutions. CFU data were pooled from three independent ex-
periments. Each data point represents one catheter (one-way ANOVA with
Tukey’s posttest).
(C) Scanning electronmicroscopic analysis of catheters 72 hr postimplant. The
catheter shown in I was removed from an uninfected mouse. Catheters in II–IV
were pretreated with PBS, peptide sP1, or peptide P1, respectively, before
implant and S. aureus inoculation. S. aureus is indicated by black triangles and
the biofilm matrix by white triangles. Scale bar, 10 mm.incubated for 18 hr at 37C, and bacterial growth in each well was confirmed
by themeasurement of OD600 using a spectrophotometer (BioTek). The super-
natant was discarded, and the wells were washed with water twice. Bacteria
associated with the well surface were dried and stained with safranin. The422 Cell Reports 9, 417–424, October 23, 2014 ª2014 The Authorsdye was then dissolved in 33% acetic acid and the absorbance quantified at
415 nm using a spectrophotometer (BioTek). Bacterial attachment on catheter
material preincubated with peptides was also investigated in biofilm assays.
Vialon TM catheters (BD Biosciences) were incubated for 18 hr in peptides dis-
solved in PBS (46 mM), washed with PBS, and incubated in stationary bacterial
suspensions (OD600 = 0.015) for 24 hr. Following removal of nonadherent bac-
teria with repeated washing, adherent bacteria and biofilms were dissociated
using sonication in PBS. Bacterial titers were quantified by plating serial dilu-
tions on agar plates and were calculated as colony-forming units (CFUs) per
catheter.
Microscopy
Bacterial infection and PNAG detection in D. melanogaster was visualized
using Carnoy’s fixed and paraffin-mounted specimens; 4 mmsections were re-
hydrated according to standard protocol and gram stained for bacterial detec-
tion. Biotinylated, succinylated wheat germ agglutinin (WGA; 3mg / ml; Vector
Labs) was used for PNAG detection, but also showed limited cross-reactivity
to components of the bacterial cell wall at higher concentrations (data not
shown). Binding was visualized using the Vectastain ABC Kit and ImmPACT
DAB peroxidase substrate (Vector Labs) and was counterstained with Hema-
toxylin QS (Vector Labs). Scanning electron microscopy was used to investi-
gate biofilm formation on explanted catheters. Following surgical removal
and a single washing step in PBS, the catheters were fixed for 1 hr at 23C
in 4% glutaraldehyde solution, washed three times in PBS, and additionally
fixed for 1 hr at 23C in 2% osmium tetroxide solution. Following repeated
washing in water, the samples were dehydrated using increasing concentra-
tions of ethanol, dried in liquid CO2 and sputter coated using the EMS 550X
(EMS). Imageswere acquired using the ISI SS40 (International Scientific Instru-
ments) operating at 10 kV.
Mouse Immunization and Antibody Generation
Polyclonal murine sera against recombinant GST-IAFGP were generated by
subcutaneous immunization of female 6–8 week old Balb/c mice with 5 mg
GST-IAFGP in Freund’s complete adjuvant. Mice were boosted twice every
8–10 days with Freund’s incomplete adjuvant and sacrificed 10 days after
the final immunization. Polyclonal sera were used for detection of IAFGP.
Fly Propagation and Fly Infection
The iafgp-expressing and mCherry-expressing flies were generated as
described (Neelakanta et al., 2012). D. melanogaster were maintained using
standard procedures (Bownes et al., 1990). The fly colony was sustained at
21C–23C. Following infection, flies were incubated at 29C to increase
upstream activation sequence-mediated transgene expression. Five- to
9-day-old females were used for experiments. Twenty to 30 flies per vial
were infected by microinjection as reviewed (Apidianakis and Rahme, 2009),
and survival was monitored. Microinjection was performed into the thorax
below the wing using a Nanojet microinjector (Drummond Scientific). Bacteria
in stationary growth phase were diluted in PBS to OD600 = 0.1, and 9.2 nl were
injected, corresponding to an infectious dose of 500–1,000 CFU per fly,
respectively. Individual flies injected with an infectious dose of 50–100 CFU
were homogenized in 500 ml PBS using a bullet blender and steel beads (Nex-
tadvance). Serial dilutions were plated on brain-heart infusion agar plates and
incubated at 37C overnight. Endogenous fly bacteria only grew to pinprick
size overnight, allowing visual distinction of the fast-growing bacteria used
for infection (data not shown). PNAG was detected in pools of five flies.
Following homogenization in 200 ml PBS, the supernatant was assayed with
immunoblot protocols described above.
Generation of an iafgp-Expressing Mouse Line
iafgp was constitutively expressed under control of the chicken b-actin pro-
moter in an iafgp-transgenic mouse line. The promoter region was excised
from pbAct-CAT 9 (ATCC) using XhoI and HindIII and subcloned into the
pEGFP-1 vector (Clontech). EGFPwas removed from pbAct-EGFP-1 by diges-
tion with BamHI and NotI, resulting in pbAct-1. iafgp was then PCR amplified
with oligomers iafgp BamHI F and iafgp NotI R and pGEMT-iafgp (Neelakanta
et al., 2010) as template, introducing the corresponding restriction sites. The
PCR fragment was digested and cloned into linearized pbAct-1, resulting in
pbAct-iafgp. For microinjection, the transgene fragment containing the b-actin
promoter and iafgp gene was excised from pbAct-iafgp by digestion with XhoI
and AflII restriction enzymes and gel purified. Microinjection was performed in
4- to 5-week-old hybrid mouse embryos (C57Bl/63C3H), andmice were gen-
otyped by PCR analysis of tail biopsies using IAFP4qRTF and IAFP4qRTR.
Full-length iafgp amplicons were confirmed, and mRNA expression in multiple
tissues was determined using the primers that were used for qRT-PCR. Trans-
genic iafgp-expressingmicewere backcrossed for eight generations to C57Bl/
6 mice (Charles River). Heterozygous or homozygous experimental mice of 6–
12 weeks were age and sex matched with wild-type littermates and wild-type
C57Bl/6 as control. All mice were housed at 20C–22Cwith water and food ad
libitum. Animal handling was performed according to protocols approved by
the Yale Animal Care and Use Committee.
Murine Challenges with Bacteria and Surgeries
CLP surgery was performed as described (Rittirsch et al., 2009). Mice were
anesthetized using isoflurane inhalation, and the cecum was exteriorized
through a peritoneal midline incision. Seventy-five percent of the cecum
was ligated and punctured through and through with a 21G hypodermic
needle. A small amount of fecal material was squeezed out, and the cecum
was reinserted into the peritoneal cavity. After closing the abdomen in two
layers, mice received 1 ml saline subcutaneously. Buprenorphine was in-
jected every 12 hr for analgesia. Sham surgeries, including cecal exterioriza-
tion but without ligation and puncture, were performed as control. Survival
and disease scores (from healthy/alert, via slightly lethargic [slightly delayed
response to experimenter, slowed movement], and lethargic [significantly
reduced response to experimenter, raised fur, slowed and reduced move-
ment] to very lethargic [body shaking, hunchback, absence of evasion
movements] and dead) were monitored several times daily. Body surface
temperature was measured dorsally using an infrared thermometer. Murine
catheter implant surgery was performed as described (Cassat et al., 2007).
Wild-type mice were anesthetized using isoflurane inhalation, and a dorsal
area was shaved. Following surface disinfection, a 3–4 mm incision was
made on each mouse flank. Using a blunt probe to form subcutaneous
pockets, 2 cm catheter tubing (BD Biosciences) was inserted into each
cavity. Incisions were sutured, and approximately 5 3 106 CFUs of exponen-
tially growing S. aureus SA113, washed and diluted in PBS, were injected
through the skin into the lumen of the catheters. At 3 days after implant,
the devices were removed, rinsed once, and then sonicated in PBS. The
number of attached bacteria was determined by plating serial dilutions on
agar plates. For monomicrobial infection, iafgp-expressing mice were in-
fected with the S. aureus MRSA isolate USA300 JE2; 1.2 3 108 CFU logarith-
mic growth phase bacteria per mouse were applied intranasally in 50 ml PBS,
and murine survival was monitored.
Miceweremonitored at regular intervals for up to 36 hr for the following signs
of moribund condition: sustained hypothermia (body temperature < 30C for
more than 1 hr, as measured by the infrared thermometer), lethargy, dehydra-
tion, change in color of mucous membranes, and labored breathing. We
determined that mice showing more than three of the indicated signs were
moribund and euthanized them promptly with CO2.
Statistical Analysis
All experiments were repeated independently at least three times, if not noted
otherwise. Statistical differences between groups were analyzed using Stu-
dent’s t test, one-way ANOVA, or two-way ANOVA with Tukey’s or Sidak’s
posttest. Differences in survival were calculated using the log rank (Mantel-
Cox) test. Contingency tables were analyzed with the chi-square test; *p <
0.05, **p < 0.01, and ***p < 0.001 were considered significant. Calculations,
analysis, and graphing were performed using Excel 2007 (Microsoft), Prism
6.0 (GraphPad Software), and CorelDraw X4 (Corel). CFU data were logarith-
mically transformed before statistical analysis.
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